CTLA-4 gene polymorphism at position+49 A > G in exon 1: a risk factor for cervical cancer in Indian women

被引:27
作者
Gokhale, Priyanka [1 ]
Kerkar, Shilpa [1 ]
Tongaonkar, Hemant [2 ,3 ]
Salvi, Vinita [4 ,5 ]
Mania-Pramanik, Jayanti [1 ]
机构
[1] Natl Inst Res Reprod Hlth, Dept Infect Dis Biol, Bombay, Maharashtra, India
[2] Tata Mem Hosp, Bombay 400012, Maharashtra, India
[3] Hinduja Hosp, Bombay, Maharashtra, India
[4] Seth GS Med Coll & KEM Hosp, Bombay, Maharashtra, India
[5] Seven Hills Hosp, Bombay, Maharashtra, India
关键词
CTLA-4; cervical cancer; HPV; India; HUMAN-PAPILLOMAVIRUS TYPE-16; SQUAMOUS-CELL CARCINOMA; COMBINATION IMMUNOTHERAPY; TUMOR-REGRESSION; BREAST-CANCER; SUSCEPTIBILITY; ASSOCIATION; CYTOTOXIC-T-LYMPHOCYTE-ANTIGEN-4; BLOCKADE; PROMOTER;
D O I
10.1016/j.cancergen.2013.04.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Single nucleotide polymorphisms (SNPs) in the CTLA-4 gene exert differential effects on T-cell response to viral infection. We aimed to evaluate the association of two SNPs of the CTLA-4 gene with cervical cancer in Indian women. The two polymorphic loci, one in the promoter region -318 C>T, rs5742909 (100 cervical cancer cases and 101 controls) and the other in exon 1 +49 A>G, rs231775 (104 cervical cancer cases and 162 controls) were genotyped using polymerase chain reaction-restriction fragment length polymorphism methods. Haplotype block structure was determined using Haploview 4.2. The statistical analyses were performed using a commercially available statistical software package, whereas PyPop was used to calculate the haplotypic frequencies. In this case-control study, the A/A genotype frequency (30.76% vs. 17.6%, P = 0.01) as well as the allelic frequency for A (52.8% vs. 43.5%, P = 0.04) was significantly higher in cases compared to controls. No significant association was seen in the -318 C>T polymorphism. In forward stepwise binary logistic regression analysis considering age and parity as potential confounders, significant association was demonstrated between +49 NA and cervical cancer. Most likely, this is the first study from India to highlight the significant association between the CTLA-4 gene +49 NA SNP and cervical cancer, thus adding to the global knowledge of the association of this SNP with cervical cancer.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 48 条
[1]
T-cell regulation by CD28 and CTLA-4 [J].
Alegre, ML ;
Frauwirth, KA ;
Thompson, CB .
NATURE REVIEWS IMMUNOLOGY, 2001, 1 (03) :220-228
[2]
Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to chronic hepatitis B [J].
Alizadeh, Amir Houshang Mohammad ;
Hajilooi, Mehrdad ;
Ranjbar, Mitra ;
Fallahian, Farahnaz ;
Mousavi, Seyed Mohsen .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (04) :630-635
[3]
Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[4]
Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease [J].
Chistiakov, DA ;
Savost'anov, KV ;
Turakulov, RI ;
Efremov, IA ;
Demurov, LM .
CLINICAL IMMUNOLOGY, 2006, 118 (2-3) :233-242
[5]
High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer [J].
Cozar, Jose M. ;
Romero, Jose M. ;
Aptsiauri, Natalia ;
Vazquez, Fernando ;
Vilchez, Jose R. ;
Tallada, Miguel ;
Garrido, Federico ;
Ruiz-Cabello, Francisco .
HUMAN IMMUNOLOGY, 2007, 68 (08) :698-704
[6]
Deeba Farha, 2010, Indian J Dermatol, V55, P29, DOI 10.4103/0019-5154.60347
[7]
DILLNER J, 2011, BEST PRACT RES CL OB, V15, P743
[8]
Allergy-associated polymorphisms of the FcεRIβ subunit do not impacts two amplification functions [J].
Donnadieu, E ;
Cookson, WO ;
Jouvin, MH ;
Kinet, JP .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3917-3922
[9]
CTLA-4: new insights into its biological function and use in tumor immunotherapy [J].
Egen, JG ;
Kuhns, MS ;
Allison, JP .
NATURE IMMUNOLOGY, 2002, 3 (07) :611-618
[10]
Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer [J].
Erfani, N ;
Razmkhah, M ;
Talei, AR ;
Pezeshki, AM ;
Doroudchi, M ;
Monabati, A ;
Ghaderi, A .
CANCER GENETICS AND CYTOGENETICS, 2006, 165 (02) :114-120